货号:GS40798
Volagidemab is an investigational antagonistic monoclonal antibody of the IgG2-kappa isotype that targets the glucagon receptor (GCGR). It is being studied as a potential treatment for Type 1 Diabetes (T1D), with the aim of blocking the hyperglycemic effects of glucagon to improve blood glucose control, particularly by reducing the risk of hypoglycemia.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物